Pfizer says once-a-month weight-loss drug works as it for...
Pfizer on Tuesday hailed a study of a weight-loss-drug candidate while forecasting a profit decline because of the impact of the Trump ad...
Whatโs Happening
Not gonna lie, Pfizer on Tuesday hailed a study of a weight-loss-drug candidate while forecasting a profit decline because of the impact of the Trump administrations policies on pricing and tariffs.
More details are expected to emerge soon.
Why This Matters
Market watchers are paying close attention to developments like this.
This reflects broader trends weโre seeing in the business world right now.
The Bottom Line
This story is still developing, and weโll keep you updated as more info drops.
Sound off in the comments.
Originally reported by MarketWatch
Got a question about this? ๐ค
Ask anything about this article and get an instant answer.
Answers are AI-generated based on the article content.
vibe check:
